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Summary
 
The killer cell inhibitory receptors (KIR) of human natural killer (NK) cells recognize human
leukocyte antigen class I molecules and inhibit NK cell cytotoxicity through their interaction
with protein tyrosine phosphatases (PTP). Here, we report that KIR recognition of class I
ligands inhibits distal signaling events and ultimately NK cell cytotoxicity by blocking the asso-
ciation of an adaptor protein (pp36) with phospholipase C-
 
g
 
 in NK cells. In addition, we dem-
onstrate that pp36 can serve as a substrate in vitro for the KIR-associated PTP, PTP-1C (also
called SHP-1), and that recognition of class I partially disrupts tyrosine phosphorylation of NK
cell proteins, providing evidence for KIR-induced phosphatase activity.
 
N
 
K cells are a subset of lymphocytes characterized by
their unique surface phenotype (CD3
 
2
 
, CD56
 
1
 
, and
CD16
 
1
 
) and spontaneous cytotoxicity toward various cel-
lular targets in vitro (1). Although the cell surface interac-
tions that stimulate NK cell cytolysis remain uncertain, the
intracellular pathways that transduce these events into cyto-
toxic activity are known in some detail and appear similar
to those of cytotoxic T cells (2, 3). Stimulation of NK cell–
mediated cytotoxicity depends on the early activation of
protein tyrosine kinases (PTK)
 
1
 
, which phosphorylate a va-
riety of cellular proteins (4, 5). One critical substrate is
phospholipase C-
 
g
 
, which upon enzymatic activation ini-
tiates the inositol 1,4,5-triphosphate (IP3)/calcium (Ca
 
11
 
)
signaling pathway through its cleavage of membrane-asso-
ciated phosphatidylinositol 4,5-bisphosphate (PIP2) (6-9).
Induction of the IP3/Ca
 
11
 
 cascade, and the distal signaling
events this pathway elicits, ultimately leads to activation of
the NK cell lytic machinery (10).
Knowledge of the mechanisms underlying NK cell cyto-
toxic specificity is fragmentary; however, a current model
envisages a balance of stimulatory and inhibitory signals
caused by interactions between receptors of NK cells and
ligands of a potential target (11). Whereas the stimulatory
receptors and ligands remain a subject for debate, two fam-
ilies of inhibitory receptors that recognize epitopes of
MHC class I molecules are well defined. The killer cell in-
hibitory receptors (KIR) are single chain molecules of the
Ig superfamily found on human but not rodent NK cells
(12–14). Conversely, the Ly-49 receptors are membrane-
associated C-type lectins identified as homodimers on mouse
and rat NK cells, but not on those of humans (15–17).
These receptors inhibit NK cell cytotoxicity after recogni-
tion of MHC class I molecules through their association
with the protein tyrosine phosphatases (PTP) PTP-1C and
-1D (18–21). In the experiments described in this report,
we examined the link between the membrane proximal
event of tyrosine phosphorylation and downstream path-
ways associated with NK function by studying the regula-
tion of PLC-
 
g
 
 activity in human NK cells inhibited by
KIR recognition of class I. Our findings suggest that the
ability of class I allotypes to inhibit NK cell cytotoxicity is
dependent on the negative signals generated through KIR
to disrupt the association of PLC-
 
g
 
 with the adaptor pro-
tein pp36.
 
Materials and Methods
 
HLA Class I Transfectants and Class I Specificity of NK Cell
Clones.
 
The HLA class I–negative B lymphoblastoid cell line
721.221 (221), provided by Dr. R. DeMars (University of Wis-
consin, Madison, WI) (22), was transfected with HLA class I cDNA
as previously described (23). NKB1
 
1
 
 NK cell clones were gener-
 
1
 
Abbreviations used in this paper:
 
 GST, glutathione-S-transferase; IP3, inosi-
tol 1,4,5-triphosphate; KIR, killer cell inhibitory receptors; PIP2, phos-
phatidylinositol 4,5-bisphosphate; PLC, phospholipase C; PTK, protein
tyrosine kinase; PTP, protein tyrosine phosphatases.
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ated and maintained as described (24) and their class I specificity
determined in standard 4-h chromium release assays. In brief,
NKB1
 
1
 
 clones were used as effector cells against a target cell
panel of 
 
51
 
Cr-labeled untransfected 221 cells and class I transfec-
tants at an effector to target (E/T) ratio of 6:1. Only those clones
that lysed untransfected target cells and transfectants expressing
Bw4
 
2
 
 HLA-B allotypes at levels exceeding 70% but did not lyse
(
 
.
 
10% specific lysis) transfectants bearing Bw4
 
1
 
 HLA-B mole-
cules were used in the study. In addition, NKB1
 
2
 
 NK cell clones
meeting these criteria but having specificity for HLA-C allotypes
(25) were also identified and used to assess the generality of the
results with NKB1
 
1
 
 clones. The NKB1 dependence of inhibition
was determined by addition of the anti-NKB1 mAb DX9 (20 
 
m
 
g/
10
 
6
 
 NK cells) to the cell-killing assays. This antibody restores lysis
of Bw4
 
1
 
 transfectants by NKB1
 
1
 
 clones but has no effect on the
lysis of other target cells or on lysis mediated by NKB1
 
2
 
 NK
clones (24).
 
Determination of Intracellular IP3 Level.
 
Generation of IP3 by
NK cells was determined using established methods (7, 26). NK
cell clones were labeled with 20 
 
m
 
Ci/ml of [
 
3
 
H]myoinositol (Du
Pont NEN, Boston, MA) in inositol-free RPMI-1640 medium
(GIBCO BRL, Gaithersburg, MD) for 18 h at 37
 
8
 
C; 7.5% CO
 
2
 
.
After washing to remove excess label, the clones (2 
 
3
 
 10
 
6
 
 cells/
sample) were resuspended in cold HBSS (1 mM CaCl
 
2
 
, 5.6 mM
glucose, 20 nM Hepes, 10 mM LiCl, pH 7.4) and combined with
an equal number of target cells on ice in the presence or absence
of mAb DX9 (20 
 
m
 
g/10
 
6
 
 NK cells). The cells were pelleted in a
microcentrifuge at 4
 
8
 
C and transferred to a 37
 
8
 
C water bath. Re-
actions were terminated at various times by addition of metha-
nol–chloroform–HCL (200:100:2), followed by extraction with
chloroform and water. IP3 levels in the aqueous phase were mea-
sured as cell-incorporated radioactivity after anion exchange
chromatography of each sample on a 1 ml Ag1-X8 column (Bio
Rad, Richmond, CA). Columns were washed with a two-step
discontinuous gradient of 0.1 M formic acid containing 0.5 M or
0.8 M ammonium formate. The radioactivity of the fraction con-
taining IP3 (the 0.8 M ammonium formate eluate) (7) was mea-
sured using a liquid scintillation counter.
 
Measurement of Intracellular Calcium Concentration.
 
NK clones were
labeled with the fluorescent calcium indicator, fluo-3/AM (Mo-
lecular Probes, Eugene, OR) according to the instructions of the
manufacturer, after which they were washed and resuspended in
PBS containing 2 mM CaCl
 
2
 
. Changes in calcium concentrations
over time in response to target cells were determined using a
FACScan
 
Ò
 
 flow cytometer (Becton Dickinson Immunocyto-
chemistry, San Jose, CA). The target cells were loaded with dihy-
droethidium (Molecular Probes) before challenge so their fluores-
cence could be distinguished from that of the NK cell clones
during flow cytometry. Each assay was performed using 2 
 
3
 
 10
 
6
 
fluo-3-labeled NK cells challenged with an equal number of tar-
get cells. Upon combination of the NK clones and targets, the
cells were pelleted by low speed centrifugation to maximize their
interaction. In some assays the cells were treated with mAb DX9
(20 
 
m
 
g/10
 
6
 
 NK cells) or the calcium ionophore A23187 (Molec-
ular Probes).
 
Tyrosine Phosphorylation Assay, SDS-PAGE and Western Blot-
ting.
 
In all experiments except those determining pp36 associa-
tion with PLC-
 
g
 
, NK cell clones were labeled (500 
 
m
 
Ci/10
 
7
 
 NK
cells) for 18 h with [
 
32
 
P]orthophosphate (Amersham Corp., Ar-
lington Heights, IL) in phosphate-free RPMI-1640 medium
(GIBCO BRL). After labeling, the cells were washed and resus-
pended (1–2 
 
3
 
 10
 
7
 
 NK cells/sample) in medium and kept on
ice. An equal number of target cells was added and the cells were
then pelleted in a microfuge at 4
 
8
 
C, followed by incubation in a
37
 
8
 
C water bath. At various times the cells were lysed with the
detergent NP-40 (1% NP-40, 1 mM PMSF, 1 
 
m
 
g/ml aprotinin,
10 
 
m
 
g/ml leupeptin, 5 mM sodium metavanadate, 50 mM NaF
in 150 mM NaCl, 10% glycerol, 20 mM Hepes, pH 7.4). For the
experiments on pp36 association with PLC-
 
g
 
, unlabeled NK cell
clones (2–3 
 
3
 
 10
 
7
 
 NK cells/sample) were challenged with target
cells and lysed using the nonionic detergent CHAPS (identical to
the lysis buffer used in the other experiments except substituting
CHAPS for NP-40). Immunoprecipitations were performed on
the postnuclear lysates using various antibodies and the precipi-
tated proteins were separated by SDS–PAGE. Before immuno-
precipitation, lysates from target cells corresponding to an equiva-
lent number of NK cells were combined with NK cell lysates
from controls (not challenged with targets) to equalize protein
concentrations in the treated and untreated samples. Antibodies
used for immunoprecipitations were the following: anti-phos-
photyrosine mAb 4G10, anti-PLC-
 
g
 
1 mAb and polyclonal anti-
sera (Upstate Biotechnology, Inc., Lake Placid, NY) and anti-
PLC-
 
g
 
2 antisera (Santa Cruz Biotechnology Inc., Santa Cruz, CA;
provided by Genetics Institute, Cambridge, MA). In some exper-
iments, precipitation with a Grb2 fusion protein coupled to agar-
ose beads (Upstate Biotechnology Inc.) was performed using the
method of Sieh et al. (27). The ability of PTP-1C to dephosphor-
ylate pp36 in vitro was determined on Grb2-precipitated pp36
from activated NK cells using a PTP-1C GST fusion protein
(Upstate Biotechnology, Inc.) according to the instructions of the
manufacturer. In experiments using labeled NK cell clones the
gels were fixed, dried, and exposed to phosphorimaging screens.
For those with unlabeled clones, the SDS–PAGE separated pro-
teins were transferred to PVDF membranes (Schleicher and
Schuell, Keene, NH) and probed initially with mAb 4G10 and
after stripping (50 mM diethylamine, 1% SDS, pH 11) with the
anti-PLC-
 
g
 
1 mAb. Proteins bound by the antibodies were de-
tected with [
 
125
 
I] goat anti–mouse Ig (Amersham Corp.) and vi-
sualized by phosphorimaging.
 
Results and Discussion
 
Recognition of Inhibitory HLA-B Allotypes (Bw4
 
1
 
) by the
KIR NKB1 Alters Stimulatory Signal Transduction Pathways in
NK Cells.
 
The goal of this investigation was to compare
pathways of signal transduction in human NK cells chal-
lenged with target cells differing only in their expression of
inhibitory and permissive HLA class I allotypes. To increase
the sensitivity of detection, we selected for NK cell clones
that killed untransfected class I–deficient target cells well
(
 
.
 
70% lysis in a standard 4-h chromium release assay), but
were efficiently inhibited by expression of an inhibitory
HLA class I allotype (
 
,
 
10% lysis) by transfectants. NK cell
clones satisfying these criteria and having different inhibi-
tory specificities were identified. The subsequent investiga-
tion focused on NK cell clones expressing the KIR NKB1
specific for HLA-B allotypes carrying the Bw4 epitope (24,
28). However, experiments were also performed on NK
cells inhibited by HLA-C allotypes and they yielded similar
results.
Generation of IP3 and the dependent increase in intra-
cellular Ca
 
11
 
 are critical steps in the activation of NK cell
cytotoxicity (7, 9). To determine whether KIR recogni- 
2245
 
Valiante et al.
 
tion of HLA class I affects generation of these second mes-
sengers, NK cell clones expressing the KIR NKB1 were
challenged with untransfected target cells and transfectants
expressing inhibitory (Bw4
 
1
 
) or permissive (Bw4
 
2
 
) HLA-B
allotypes. The NK cells were prelabeled with [
 
3
 
H]myo-
inositol, so that after addition of target cells the kinetics of
IP3 generation could be measured (Fig. 1 
 
A
 
). Only those
target cells that were lysed by the NK cells induced accu-
mulation of IP3, and no difference was observed between
untransfected target cells and those transfected with a Bw4
 
2
 
HLA-B allele. In contrast, target cells transfected with a
Bw4
 
1
 
 HLA-B allele induced no changes in intracellular
IP3 levels. Analogous experiments were performed to mea-
sure increases in intracellular Ca
 
11
 
 concentration in NK
cells labeled with the fluorescent calcium indicator, fluo-3.
The results paralleled those of the experiments to measure
IP3: a Ca
 
11
 
 flux was induced by untransfected target cells
and those transfected with a Bw4
 
2
 
 HLA-B allele, but not
by a transfectant expressing a Bw4
 
1
 
 HLA-B molecule (Fig.
1 
 
B
 
). That the inhibition of IP3 and Ca
 
11
 
 mobilization in-
duced by a Bw4
 
1
 
 HLA-B molecule was eliminated by in-
clusion of a mAb specific for the KIR NKB1 during stimu-
lation (Fig. 1 
 
C
 
 and 
 
D
 
, respectively) demonstrates that the
changes in second messengers are dependent upon interac-
tion of KIR and HLA class I.
Early activation of PTK is required for stimulation of
NK cell–mediated cytotoxicity (4, 5). A coarse measure-
ment of cellular PTK activity is the extent of tyrosine phos-
phorylation, which can be obtained by precipitation of
PTK substrates from cell lysates using anti-phosphotyrosine
(anti-p-Tyr) antibodies (29). This approach was taken to
assess the effects of KIR recognition of class I on NK cell
PTK activity. NK clones prelabeled with 
 
32
 
P were chal-
lenged with a panel of target cells similar to those used in
the experiments measuring IP3 and calcium (Fig. 2). A par-
tial deficiency in tyrosine phosphorylation was observed in
NKB1
 
1
 
 NK cells after recognition of inhibitory HLA-B al-
lotypes. In comparison to unchallenged cells, six distinct
Figure 1. NKB1 recognition
of Bw41 HLA-B class I allotypes
inhibits IP3 generation and cal-
cium flux in NK cells. (A) The
NKB11 NK cell clone EN1.6
was labeled with [3H]myoinosi-
tol, and IP3 levels were deter-
mined at various times after chal-
lenge with different target cells:
(j) untransfected 221 cells, (d)
HLA-B*5501 (Bw42) transfec-
tant and (m) 2B*5801 (Bw41)
transfectant. Assays were per-
formed in triplicate and results
are presented as mean cpm 6
SD. In control cell killing assays
performed at the same time, the
sensitivities of the target cells to
lysis by clone EN1.6 were the
following: untransfected 221
cells (94.9%); Bw42 transfectant
(99.6%); and Bw41 transfectant
(6.5%). (B) Clone EN1.6 was la-
beled with the fluorescent cal-
cium indicator, fluo-3. After chal-
lenge with target cells (at 60 s)
changes in fluorescence were re-
corded over time using a flow cy-
tometer. Target cells were the fol-
lowing: untransfected 221 cells
(left); HLA-B*5501 (Bw42) transfectant (center), and 2B*5101 (Bw41) transfectant (right). Addition (at 330 s) of a calcium ionophore (10 nM A23187) to
the NK clone challenged with Bw41 transfectants demonstrated that increased calcium levels in the NK cells could be detected under these conditions
(right). The sensitivities of the target cells to lysis were the same as in (A) except that the HLA-B*5101 (Bw41) transfectant was lysed by clone EN1.6 at
4.7%. (C) The NK clone JG1.6 (NKB11) was challenged for 2 min with the indicated target cells in the presence (striped bar) or absence (solid bar) of an
anti-NKB1 antibody (mAb DX9). IP3 levels were determined for triplicate samples and the results are presented as percent increase over untreated con-
trols 1 SD. The basal IP3 level (cpm) in untreated NK cells was 250 6 26 (mean 6 SD). The sensitivities of the target cells to lysis by clone JG1.6 were
the following: untransfected 221 cells 92.4% without antibody and 89.7% with mAb DX9; HLA-B*5501 (Bw42) transfectant 93.1% without antibody
and 86.3% with mAb DX9; and HLA-B*5101 (Bw41) transfectant 2.4% without antibody and 76.5% with mAb DX9. Control cell killing and IP3 assays
were also performed in the presence of an anti-CD56 antibody (mAb L185), which had no effect on target cell lysis or IP3 accumulation (data not
shown). (D) Fluo-3-labeled NK cells (clone PP1.13) were analyzed by flow cytometry after interaction with Bw41 target cells with or without addition of
mAb DX9. Changes in fluorescence were recorded over time after challenge (at 60 s) with HLA-B*2705 (Bw41) transfectants. The sensitivities of the
target cells to lysis by clone PP1.13 were the following: 1.1% without antibody and 76.9% with mAb DX9. Calcium concentration was also determined
in clone PP1.13 after challenge with untransfected target cells and Bw42 transfectants and the presence of the DX9 mAb did not alter the ability of the
NK cells to flux calcium (data not shown). As for (C), the presence of an anti-CD56 antibody did not affect target cell lysis or the accumulation of cal-
cium (data not shown).2246 Inhibitory Signals of NK Cells Target the Adaptor Protein pp36
protein species of NK cells increased their phosphorylation
when the NK cells interacted with stimulatory targets (un-
transfected target cells and Bw42 transfectants). For only
three of the six proteins was phosphorylation increased
when the clones were challenged with transfectants ex-
pressing Bw41 HLA-B molecules. In addition, the dephos-
phorylation of a 55–65 kD protein was seen after challenge
of NK cells with each target cell. Although class I recogni-
tion potentially induces the specific phosphorylation of cer-
tain proteins, for example, KIR (18), we did not observe
the induction of tyrosine phosphorylated proteins unique
to NK cells inhibited by class I.
The failure of NKB11 NK cells to generate IP3 in re-
sponse to transfected target cells expressing inhibitory HLA-B
(Bw41) alleles suggested the disruption of an upstream sig-
naling event. That tyrosine phosphorylation was reduced in
this situation led us to the hypothesis that phosphorylation
of PLC-g may be blocked by KIR recognition of inhibi-
tory class I molecules. PLC-g is an important propagator of
cellular signals that requires phosphorylation for enzymatic
activation and serves to link early PTK activity with the
IP3/Ca11 cascade (30, 31). Therefore, we examined the
phosphorylation of this enzyme by immunoprecipitating
PLC-g from cell lysates of 32P-labeled NK cells previously
challenged with different target cells (Fig. 3). Contrary to
our hypothesis, phosphorylation of PLC-g1 was increased
in the NK cells compared with unstimulated controls re-
gardless of whether the target cell expressed an inhibitory
HLA-B (Bw41) allele (Fig. 3 A). Similarly, KIR recogni-
tion of inhibitory allotypes did not alter the increased phos-
phorylation of the other PLC-g isoform expressed in NK
cells, PLC-g2 (Fig. 3 B). In control experiments performed
simultaneously with the same NK/target cell pairs, the abil-
ity of the different target cells to induce IP3 accumulation
in the clones correlated with their sensitivity to lysis (Fig.
3 C and D). Moreover, the kinetics of PLC-g1 phosphory-
lation were not affected by NK cell recognition of class I
(Fig. 3 E). Thus, the negative signal caused by KIR binding
Figure 2. Challenge with tar-
get cells bearing inhibitory class I
molecules (Bw41) partially dis-
rupts tyrosine phosphorylation in
NKB11 NK cells. Labeled 32P
NK cells (clone EN1.4) were in-
cubated for 5 min in medium
alone or in the presence of un-
transfected target cells or trans-
fectants expressing Bw41 or
Bw42 HLA-B alleles. Tyrosine-
phosphorylated proteins were
precipitated from cell lysates us-
ing the anti-phosphotyrosine an-
tibody mAb 4G10, separated by
SDS–PAGE (5–20% continuous
gradient), and visualized using a phosphorimager. The mobilities of mo-
lecular mass (kD) markers are indicated on the left side of the gel. In con-
trol experiments performed at the same time, the sensitivities of the target
cells to lysis by clone EN1.14 were the following: untransfected 221 cells
(99.4%); HLA-B*5101 (Bw41) transfectant (6.2%); and 2B*4601
(Bw42) transfectant (95.9%). The pattern of tyrosine-phosphorylated
proteins shown for this clone is representative of those observed in three
other NKB11 (Bw4-specific) and three other NKB12 (HLA-C-specific)
clones tested, although the intensity of some bands varied in different as-
says (data not shown).
Figure 3. PLC-g phosphorylation in NK cells is not inhibited by
NKB1 recognition of Bw41 HLA-B allotypes. (A) NKB11 NK clones
(EN2.1, 2.2, and 2.15) were labeled with 32P and challenged for 5 min
with target cells: untransfected 221 cells (221), HLA-B*5101 (Bw41)
transfectant, and 2B*5501 (Bw42) transfectant. PLC-g1 was immunopre-
cipitated from the cell lysates using an anti-PLC-g1 mAb, and the immu-
noprecipitates were separated by SDS-PAGE (10%) and visualized using a
phosphorimager. The phosphorylated species observed (PLC-g1 .) mi-
grated at an apparent molecular mass of 140–150 kD. (B) PLC-g1 or -g2
were precipitated from cell lysates using an anti-PLC-g1 mAb or anti-
PLC-g2 antisera, respectively, following challenge of the 32P-labeled NK
clone (AL95.12) with the target cell panel (A). The phosphorylated pro-
teins detected under the various conditions following SDS-PAGE (10%)
migrated at an apparent molecular mass (140–150 kD) consistent with
their identity as PLC-g1 and -g2. (C) The same target cells were tested
for their ability to induce the generation of IP3 in the [3H]myoinositol-
labeled NK clones as described in Materials and Methods. NK/target cell
pairs were incubated for 2 min and results are presented as the mean cpm
of replicate samples. Basal IP3 levels (mean cpm) in the untreated NK
clones were the following: EN2.1 (154); EN2.2 (88); EN2.15 (121); and
AL95.12 (135). Target cells used were the following: untransfected 221 cells
(solid bars); HLA-B*5101 (Bw41) transfectant (striped bars); and 2B*5501
(Bw42) transfectant (open bars). (D) Control cell killing assays were per-
formed using the same NK clones (A and B) and, as targets, untransfected
221 cells (solid bars); HLA-B*5101 (Bw41) transfectant (striped bars); and
2B*5501 (Bw42) transfectant (open bars). (E) The phosphorylation of
PLC-g1 in 32P-labeled NK cells (clone AL95.14) was determined at the
indicated times (min) after challenge with target cells as previously described
(A and B). The values in parentheses correspond to results from control
cell killing experiments with the NK/target cell pairs performed before this
analysis. The positions of molecular mass markers are indicated at the right.2247 Valiante et al.
to an inhibitory class I molecule does not act by blocking
PLC-g phosphorylation.
Negative Signaling Through the KIR NKB1 Alters the Bind-
ing Properties of the Adaptor Protein pp36. The unexpected
finding that in NK cells inhibited by class I recognition,
PLC-g is phosphorylated in the absence of IP3 generation,
led us to investigate the possible role of the adaptor protein
pp36 in regulating PLC-g activity. Adaptor proteins con-
tain structural motifs that allow them to bind diverse signal-
ing molecules, thereby linking distinct pathways of signal
transduction (32). The pp36 adaptor protein is a 36–38 kD
phosphotyrosine containing protein that associates with
PLC-g and another adaptor protein, Grb2, after T cell acti-
vation (27). Binding of pp36 to PLC-g is believed to be re-
quired for the generation of IP3 (33), and pp36 phosphory-
lation has been observed in NK cells following stimulation
through CD16 (34). Recently, a protein of similar molecu-
lar mass that binds PLC-g and Grb2 in activated rat T cells
and having structural motifs consistent with an adaptor pro-
tein has been cloned and is considered the rodent homo-
logue of human pp36 (35). Thus, negative regulation of
pp36 function after KIR recognition of class I might con-
trol PLC-g activity in NK cells.
To test this hypothesis, we investigated the effects of
KIR recognition of class I on the association of pp36 with
PLC-g in vivo (Fig. 4) or with the Grb2 adaptor protein in
vitro (Fig. 5). The results of these experiments suggested
that negative signaling through KIR disrupts the binding of
Figure 4. NKB1 recognition of inhibitory (Bw41) HLA-B allotypes
disrupts the association of PLC-g with the pp36 adaptor protein. (A) The
NK cell clone PP1.69 was incubated for 5 min in medium alone (control)
or challenged with an equal number of Bw42 or Bw41 target cells in the
presence or absence of the anti-NKB1 antibody mAb DX9. After incuba-
tion, the cells were lysed in nonionic detergent (1% Chaps) and PLC-g
was precipitated using a combination of antisera specific for PLC-g1 and
-g2. Following SDS–PAGE (12.5%) and transfer to PVDF membranes,
tyrosine-phosphorylated proteins were detected by Western blotting us-
ing mAb 4G10 (anti-p-Tyr). The position of molecular mass markers are
indicated (left). In control cell killing assays performed at the same time
the sensitivities of the target cells to lysis by clone PP1.69 were the fol-
lowing: HLA-B*1501 (Bw42) transfectant (88.5% without antibody and
79.2% with mAb DX9); and HLA-B*2705 (Bw41) transfectant (3.0%
without antibody and 82.7% with mAb DX9). (B) The same membranes
were stripped and reprobed with a mAb specific for PLC-g1. The de-
tected band migrated at an identical position as the high molecular mass
(140–150 kD) tyrosine-phosphorylated species detected in all but the
control lane of the mAb 4G10 probed blot shown in (A).
Figure 5. Recognition of inhibitory class I molecules blocks the ability
of pp36 to bind Grb2 in vitro and pp36 serves as a substrate for PTP-1C
(also called SHP-1). (A) NK cells (clone EN5.4) prelabeled with 32P were
incubated alone or with target cells in the presence or absence of the anti-
NKB1 antibody mAb DX9. After this treatment, the cells were lysed with
NP-40 buffer and precipitations were performed using a Grb2 fusion pro-
tein. The Grb2 precipitates were separated by SDS-PAGE (12.5%) and
the positions of the molecular mass markers are shown (left). In control
cell killing assays performed at the same time the sensitivities of the target
cells to lysis by clone EN5.4 were the following: HLA-B*1501 (Bw42)
transfectant (76.4% without antibody and 83.7% with mAb DX9); and
HLA-B*2705 (Bw41) transfectant (2.1% without antibody and 73.8%
with mAb DX9). (B) 32P-labeled NK cells were challenged with untrans-
fected target cells for 5 min and pp36 was precipitated using a Grb2 fusion
protein as in (A). After washing, the precipitated material was divided in
two and either incubated (30 min at 378C) in buffer alone (control) or in
buffer containing a PTP-1C fusion protein (PTP-1C) according to the in-
structions of the manufacturer. The treated and untreated samples were sepa-
rated by SDS-PAGE (12.5%) and the positions of molecular mass markers
are shown (left).2248 Inhibitory Signals of NK Cells Target the Adaptor Protein pp36
pp36 to these two proteins. Tyrosine-phosphorylated pp36
associated with PLC-g was detected by immunoprecipitat-
ing PLC-g from nonionic detergent cell lysates followed by
Western blotting with an anti-p-Tyr antibody (see Fig. 4 A)
(27). A phosphotyrosine-containing protein of 34–38 kD
(pp36) was observed only under conditions that activated
NK cell cytotoxicity: challenge with Bw42 transfectants in
the presence or absence of an anti-NKB1 antibody and
with Bw41 transfectants only after addition of the anti-
NKB1 antibody. Importantly, this phosphorylated species
was not observed in control (unchallenged) NK cells or in
NK cells inhibited by KIR recognition of Bw41 HLA-B
alleles. Unlike pp36, tyrosine-phosphorylated PLC-g was
detected after challenge with target cells bearing either in-
hibitory (Bw41) or permissive (Bw42) alleles and addition
of an anti-NKB1 antibody did not alter the phosphoty-
rosine content of this molecule (see Fig. 4 A and B). Be-
cause pp36 forms a complex with PLC-g and the Grb2
adaptor protein in activated lymphocytes (27), we investi-
gated the in vitro binding of pp36 to Grb2 using a Grb2 fu-
sion protein to precipitate proteins from 32P-labeled NK
cells (Fig. 5 A). Similar to the effect seen for pp36 binding
to PLC-g, KIR recognition of inhibitory class I molecules
disrupted the ability of pp36 to associate with Grb2 in
vitro. Furthermore, phosphorylated pp36 precipitated with
the Grb2 fusion protein was a substrate for PTP-1C in
vitro (Fig. 5 B). Together, these findings suggest that the
negative signal generated in NK cells after class I recogni-
tion focuses on disrupting the function of pp36 as an adap-
tor protein.
In this study, we have identified a mechanism for regu-
lating PLC-g activity, whereby a negative signal generated
through KIR inhibits completely the IP3/calcium cascade
and cytotoxic activity of NK cells. Our findings suggest that
KIR recognition of class I, while not affecting the phos-
phorylation of PLC-g itself, functionally inactivates this en-
zyme by disrupting the ability of the pp36 adaptor protein
to form a signaling complex with PLC-g and Grb2 in NK
cells. It is likely that activation of KIR-associated PTP re-
sults in the inhibition of pp36 phosphorylation, which would
be consistent with the loss of pp36 binding to Grb2 (27)
and the ability of PTP-1C to dephosphorylate pp36 in vitro
that we observed. However, given our unexpected findings
on PLC-g phosphorylation and the lack of available anti-
bodies specific for pp36, predictions as to the status of pp36
phosphorylation must be viewed cautiously. Although the
ability of PTP to antagonize pp36 phosphorylation is de-
batable, our results demonstrating that KIR recognition of
class I partially abrogates tyrosine phosphorylation in NK
cells provide evidence for direct and/or indirect effects of
phosphatase activity in negative signaling. Here, our results
differ from those of a previous study (26) reporting that ty-
rosine phosphorylation was not inhibited by NK cell rec-
ognition of class I. Although technical differences could ac-
count for these disparate findings, we favor an explanation
based on the concept that competition between positive
and negative signaling events determine the threshold and
potency of NK cell responses. With this view, the ability to
detect changes in each of these competing signals could de-
pend upon their relative strengths. This model can also ex-
plain why partial inhibition by class I has no discernible ef-
fect on the accumulation of IP3 and Ca11 in NK cells (36)
and it was in anticipation of such complications that we se-
lected NK/target cell pairs where positive and negative sig-
nals were maximized.
The study of inhibitory interactions in the immune re-
sponse have led not only to an appreciation of the nature of
specific negative signals and their common themes, but also to
enhanced understanding of the well-characterized stimula-
tory pathways. Thus, the longstanding view that early in-
duction of PTK activity is central to lymphocyte activation
has been bolstered by the findings that inhibition of T cell
responses by antagonistic peptides (37, 38) or CTLA-4 (39);
of B cell activation by FcgRIIB or CD22 (40, 41) and of
NK cell cytotoxicity by class I (this study) all appear to act
at the level of tyrosine phosphorylation. Furthermore, the
inhibitory receptors of these lymphocyte populations often
use tyrosine phosphatases to antagonize PTK activity (18,
39–41). As emphasis is placed on dissecting the effects of
negative signaling in these and other systems, it is likely that
more common principles will emerge. The role of adaptor
proteins in facilitating the association of signaling molecules
is central to linking various pathways of signal transduction
to produce different functions. Emphasizing the impor-
tance of this role are our results demonstrating that the
negative signals of NK cells may focus on regulating the
function of the pp36 adaptor protein rather than directly
inhibiting PLC-g phosphorylation. Targeting inhibitory
signaling pathways toward adaptor proteins rather than sig-
naling enzymes themselves has the advantage of potentially
blocking multiple stimulatory pathways simultaneously, and
thus may have broad application in negative signaling.
Marengere and coworkers (39) have reported that the adap-
tor protein p52shc is hyperphosphorylated in T cells from
CTLA-42/2 mice. Moreover, PLC-g phosphorylation in
the absence of IP3 generation has been observed in T cells
transfected to express molecularly engineered protein ty-
rosine phosphatases at the plasma membrane (33), includ-
ing PTP-1C (Musci, M.A., S.L. Beaves, S.E. Ross, Y.
Taolin, and G.A. Koretsky, manuscript submitted for pub-
lication). Importantly, the transfected phosphatases block
the association of pp36 with PLC-g, suggesting that regula-
tion of PLC-g activity by this adaptor protein may be a
strategy employed by a range of cell types.
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